Current Validated Clinical and Patient Reported Disease Outcome Measures in Juvenile Idiopathic Arthritis

被引:6
作者
Balay-Dustrude, Erin [1 ,2 ,3 ]
Shenoi, Susan [1 ,2 ]
机构
[1] Univ Washington, Dept Pediat, Div Rheumatol, Seattle, WA USA
[2] Seattle Childrens Hosp & Res Ctr, Dept Pediat Rheumatol, Seattle, WA USA
[3] Seattle Childrens Hosp, MA 7-110,4800 Sand Point Way NE, Seattle, WA 98105 USA
关键词
JIA; clinical outcome measures; patient reported outcomes; DISABILITY MEASUREMENT TOOL; RHEUMATOID-ARTHRITIS; SELECT CATEGORIES; ACTIVITY SCORE; PRELIMINARY DEFINITION; INITIAL VALIDATION; CRITERIA; CHILDREN; RADIOGRAPHS; REMISSION;
D O I
10.2147/OARRR.S261773
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Juvenile idiopathic arthritis (JIA) is a common chronic illness in childhood and comprises seven categories based on the International League of Associations for Rheumatology (ILAR) criteria. Accurate assessment and measurement of the clinical, functional, and quality of life outcomes of patients with JIA are paramount for understanding the disease course and formulating effective treatment strategies. Interest in the development and use of outcome measurements specifically focused on rheumatologic conditions has greatly expanded over the last two decades, adding to and improving upon the established disease measures. Furthermore, many of these measures have been validated using the widely accepted Outcome Measures in Rheumatology (OMERACT) core principles of instrument validation, allowing researchers and clinicians to gain confidence in these tools. This review summarizes the current validated disease outcome measures in JIA, including clinical, imaging, patient-reported, and functional outcome measurement tools, and highlights ongoing work that continues to refine and improve upon the available tools. The clinical disease outcome measures discussed in this review include physician global assessment (PhGA), American College of Rheumatology (ACR, Wallace) criteria for clinical inactive disease and clinical remission, juvenile arthritis disease activity scores (JADAS), juvenile spondyloarthritis disease activity index (JSPaDA), juvenile arthritis damage index (JADAI), and the ACR pediatric response scores. The imaging outcome measures discussed include the Dijkstra composite scores, childhood arthritis radiographic score of the hip (CARSH), and Poznanski Score. The patient-reported disease outcome measures discussed include patient global assessment (PtGA), patient-reported outcome measurement information system for JIA (PROMIS), juvenile arthritis parent/child centered disease assessment index (JAPAI, JACAI), juvenile arthritis multidimensional assessment report (JAMAR), and the Pediatric quality of life inventory rheumatology module (PedsQL). The functional outcome tools discussed include the Childhood Health Assessment Questionnaire (CHAQ), juvenile arthritis functionality scale and index (JAFS and JASI), and Juvenile Arthritis Functional Assessment Report and Scale (JAFAS and JAFAR).
引用
收藏
页码:189 / 206
页数:18
相关论文
共 55 条
[1]   Developing the Patient-Reported Outcomes Measurement Information System (PROMIS) [J].
Ader, Deborah N. .
MEDICAL CARE, 2007, 45 (05) :S1-S2
[2]   Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis [J].
Alongi, Alessandra ;
Giancane, Gabriella ;
Naddei, Roberta ;
Natoli, Valentina ;
Ridella, Francesca ;
Burrone, Marco ;
Rosina, Silvia ;
Chedeville, Gaelle ;
Alexeeva, Ekaterina ;
Horneff, Gerd ;
Foeldvari, Ivan ;
Filocamo, Giovanni ;
Constantin, Tamas ;
Ruperto, Nicolino ;
Ravelli, Angelo ;
Consolaro, Alessandro .
RMD OPEN, 2022, 8 (01)
[3]  
[Anonymous], What is PROMIS? PROMIS Health Organization
[4]   Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same way [J].
Backstroem, Maria ;
Tarkiainen, Maarit ;
Gottlieb, Beth S. ;
Trincianti, Chiara ;
Qiu, Tingting ;
Morgan, Esi ;
Lovell, Daniel J. ;
Bovis, Francesca ;
Loeyttyniemi, Eliisa ;
Ruperto, Nicolino ;
Vahasalo, Paula ;
Consolaro, Alessandro .
RHEUMATOLOGY, 2023, 62 (10) :3421-3426
[5]   Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis [J].
Backstrom, Maria ;
Tynjala, Pirjo ;
Aalto, Kristiina ;
Gronlund, Minna-Maija ;
Ylijoki, Heikki ;
Putto-Laurila, Anne ;
Karki, Johanna ;
Keskitalo, Paula ;
Sard, Sirja ;
Pohjankoski, Heini ;
Hietanen, Maiju ;
Witter, Silke ;
Lehto, Helena ;
Loyttyniemi, Eliisa ;
Vahasalo, Paula .
RMD OPEN, 2019, 5 (01)
[6]  
Beaton D, The OMERACT Handbook
[7]   Development and Initial Validation of a Radiographic Scoring System for the Hip in Juvenile Idiopathic Arthritis [J].
Bertamino, Marta ;
Rossi, Federica ;
Pistorio, Angela ;
Lucigrai, Giorgio ;
Valle, Maura ;
Viola, Stefania ;
Magni-Manzoni, Silvia ;
Malattia, Clara ;
Martini, Alberto ;
Ravelli, Angelo .
JOURNAL OF RHEUMATOLOGY, 2010, 37 (02) :432-439
[8]   Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology [J].
Bovis, Francesca ;
Consolaro, Alessandro ;
Pistorio, Angela ;
Garrone, Marco ;
Scala, Silvia ;
Patrone, Elisa ;
Rinaldi, Mariangela ;
Villa, Luca ;
Martini, Alberto ;
Ravelli, Angelo ;
Ruperto, Nicolino .
RHEUMATOLOGY INTERNATIONAL, 2018, 38 :5-17
[9]   Patient-Reported Outcomes Measurement Information System Tools for Collecting Patient-Reported Outcomes in Children With Juvenile Arthritis [J].
Brandon, Timothy G. ;
Becker, Brandon D. ;
Bevans, Katherine B. ;
Weiss, Pamela F. .
ARTHRITIS CARE & RESEARCH, 2017, 69 (03) :393-402
[10]   Biologic therapy for systemic juvenile idiopathic arthritis—times they are a'changing! [J].
Jenny Buckland .
Nature Reviews Rheumatology, 2013, 9 (2) :63-63